Through the acquisition of Versantis for €40m upfront and further €65m in milestones, Genfit SA has added three clinical and preclinical candidates to its liver drug portfolio.
Oslo-based Lytix Biopharma has a new Chief Business Officer. Stephen Worsley has started at the Norwegian immune-oncology company at the beginning of September.
Dutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings.
https://european-biotechnology.com/wp-content/uploads/2024/04/AML_Auer_rods.png14401548Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-09-06 13:31:052024-04-04 16:45:54Pleco Therapeutics raises €17.3m in Series A
Synaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence.
https://european-biotechnology.com/wp-content/uploads/2024/04/EBM322_Pascal_Bricout_kl.jpg822731Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2022-09-06 12:37:002024-07-16 17:42:18New Head of Finance for Carbios
https://european-biotechnology.com/wp-content/uploads/2024/04/BioEcho-Boston-_6553739_7_2022_06.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-09-02 09:34:002024-04-04 16:45:57BioEcho Life Sciences launches US subsidiary
Genfit swallows Versantis in €105m deal
Latest NewsThrough the acquisition of Versantis for €40m upfront and further €65m in milestones, Genfit SA has added three clinical and preclinical candidates to its liver drug portfolio.
Food specialist Standing Ovation SA raises €12m
Latest NewsFoodtech startup Standing Ovation SA has closed an oversubscribed €12m Series A financing round led by Astanor Ventures.
Lytix Biopharma: CBO-Position new filled
AppointmentsOslo-based Lytix Biopharma has a new Chief Business Officer. Stephen Worsley has started at the Norwegian immune-oncology company at the beginning of September.
HeartBeat.bio inks partnership with Molecular Devices
Latest NewsHeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput drug discovery screening
Mobile app recognises COVID-19 infection
Latest NewsDutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings.
Pleco Therapeutics raises €17.3m in Series A
Latest NewsDutch Pleco Therapeutics BV has raised €17.3m in a Series A financing to push its lead candidate in acute myeloid leukaemia to market approval.
Emergence Therapeutics licences Synaffix platform
Latest NewsSynaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence.
New Head of Finance for Carbios
AppointmentsFinance Expert Pascal Bricout strengthens French Carbios as Chief of Strategy; Financial Officer and a member of the Executive Committee.
Abivax SA bags €49.2m to push ABX-464
Latest NewsParis-based Abivax SA has cashed in €49.2m in an oversubscribed financing with top-tier US and European biotech investors.
BioEcho Life Sciences launches US subsidiary
Latest NewsGerman nucleic acid extraction specialist BioEcho Life Sciences has opened a subsidiary in Boston to supply the huge US-american market.